Detalhe da pesquisa
1.
Cost-utility analysis and budget impact of benralizumab as add-on therapy to standard care for severe eosinophilic asthma in Colombia.
Expert Rev Pharmacoecon Outcomes Res
; 22(2): 299-305, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-34143703